Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NovaBay Pharmaceuticals Inc. (NBY)

0.2874   -0.043 (-12.94%) 05-22 15:59
Open: 0.281 Pre. Close: 0.3301
High: 0.3198 Low: 0.261
Volume: 471,697 Market Cap: 5M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.312 - 0.315 0.315 - 0.317
Low: 0.264 - 0.268 0.268 - 0.27
Close: 0.286 - 0.292 0.292 - 0.295

Technical analysis

as of: 2019-05-22 4:25:48 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.98     One year: 1.42
Support: Support1: 0.23    Support2: 0.19
Resistance: Resistance1: 0.84    Resistance2: 1.22
Pivot: 0.60
Moving Average: MA(5): 0.36     MA(20): 0.69
MA(100): 1.19     MA(250): 1.56
MACD: MACD(12,26): -0.20     Signal(9): -0.17
Stochastic oscillator: %K(14,3): 9.34     %D(3): 12.65
RSI: RSI(14): 33.56
52-week: High: 3.75  Low: 0.23  Change(%): -88.3
Average Vol(K): 3-Month: 44003  10-Days: 246167

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NBY has closed above bottom band by 21.0%. Bollinger Bands are 85.9% wider than normal. The large width of the bands suggest high volatility as compared to NBY's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Wed, 17 Apr 2019 12:26:51 Z
NovaBay Pharmaceuticals Receives Non-Compliance Letter From NYSE American

Mon, 01 Apr 2019 18:17:31 Z
NovaBay Pharmaceuticals Discloses $5 Mln Investment to Support Growth of Avenova

Thu, 28 Mar 2019 21:08:34 Z
NovaBay Pharmaceuticals Swings to Loss in Q4 from Year Ago Amid Falling Revenue

Thu, 28 Mar 2019 19:01:04 Z
After-Hours Earnings Report for March 28, 2019 : SAIC, RH, PRGS, OXM, SGH, NH, REED, VJET, BOXL, NBY, CAPR, BIOC

Tue, 12 Mar 2019 21:26:52 Z
NovaBay Pharmaceuticals Cuts Jobs in US in Avenova Sales Shift, Names Chairman, New Interim President and CEO and New Interim CFO

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18.99
Shares Float (M) 17.21
% Held by Insiders
% Held by Institutions 1.20
Shares Short (K) 68
Shares Short P. Month (K)

Stock Financials

EPS -0.490
EPS Est. Current Year -0.470
EPS Est. Next Year -0.090
EPS Est. Next Quarter -0.030
Forward EPS -0.170
Book Value (p.s.) 21.300
PEG Ratio
Profit Margin -84.37
Operating Margin -86.63
Return on Assets (ttm) -82.4
Return on Equity (ttm) -218.3
Qtrly Rev. Growth -49.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -0.59
P/E Growth Ratio -0.13
P/BV 0.01
P/S 7622732.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-12-21
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.